DOTCHIN & ASSOCIATES, LLC for EMERGENT BIOSOLUTIONS
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
FY 2020 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government Re-authorization of the Pandemic and All-Hazards Preparedness Act NDAA - provisions related to biological and chemical defense Department of Defense appropriations for Medical Countermeasures
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT J. DOTCHIN | — |
Homeland Security HOM
FY 2020 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government Re-authorization of the Pandemic and All-Hazards Preparedness Act NDAA - provisions related to biological and chemical defense
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT J. DOTCHIN | — |
Health Issues HCR
FDA regulatory issues Issues related to Priority Review Voucher programs Opioid and heroin addiction legislation, Naloxone access, coprescribing/opioid prescribing guidelines
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT J. DOTCHIN | — |
Defense DEF
NDAA - provisions related to biological and chemical defense Department of Defense appropriations for Medical Countermeasures
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT J. DOTCHIN | — |
Disaster Planning/Emergencies DIS
FY 2020 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government Re-authorization of the Pandemic and All-Hazards Preparedness Act NDAA - provisions related to biological and chemical defense
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT J. DOTCHIN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.